Sulfoximine-substituted trifluoromethylpyrimidine analogs as inhibitors of proline-rich tyrosine kinase 2 (PYK2) show reduced hERG activity

200986 citationsJournal Articlegreen Open Access

Authors

Good health and well-being

Published in: Bioorganic & Medicinal Chemistry Letters

Volume 19, Issue 12, pp. 3253-3258

Field-Weighted Citation Impact: 1.48